Medical Letter on the CDC and FDA

Drug Development - NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application

Dynavax Technologies Corporation - Dynavax Announces Path for HEPLISAVTM Hepatitis B Vaccine Development

Exact Sciences Corp. - Exact Sciences Announces Appointment of Diagnostics Veteran Graham Lidgard as Chief Scientific Officer

Flu Vaccines - Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials

Freedom Meditech, Inc. - Freedom Meditech, Inc. Secures Second Tranche of Series a Financing

Gaucher Disease - Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA

Genzyme Corporation - Genzyme Provides Update on Allston Landing Plant

Graceway Pharmaceuticals, LLC - Data Demonstrate New Imiquimod Formulation as Short Course Treatment for Actinic Keratosis

Guiding Stars - Americans Seek Simpler Solutions to Interpreting the Nutrition Facts Panel & Identifying Healthy Foods

Hard to Treat Diseases - Hard to Treat Diseases, Inc. HTDS Thai Registration Dossier

Headache and Migraine - Zogenix and Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved Sumavel(TM) DosePro(TM)

Heart Failure - MULTAQ® (dronedarone) for Atrial Fibrillation or Atrial Flutter Now Available in the United States

HIV/AIDS - GeoVax Labs, Inc. Provides Clinical Studies Update

HIV/AIDS - President Clinton and Mylan Chairman and CEO Robert J. Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug-Resistant HIV in Developing Countries

Honeywell - Honeywell's Low-Global-Warming Refrigerant for Vehicles Approved for Import, Use By Japan Regulators

Hypercholesterolemia - FDA Approves LIVALO(R) for Primary Hypercholesterolemia and Combined Dyslipidemia

Hypertension - FDA approves Tekturna HCT® as initial treatment in patients unlikely to achieve their blood pressure goals with a single agent

Immunotec INC. - Immunotec Announces an Independent, Clinical Research Initiative at Beaumont Hospitals' Hospital's Community Clinical Oncology Program CCOP. This Pilot Study is Supported by the Moffitt Cancer Center CCOP Research Base C

Influenza - Transfusion Journal Supplement Focuses on Identification of 68 Emerging Infectious Disease Agents

King Pharmaceuticals, Inc. - King Pharmaceuticals Reports Second Quarter 2009 Financial Results

Labopharm Inc. - Labopharm Reports Results for Second Quarter Fiscal 2009

Law Offices of Howard G. Smith - Law Offices of Howard G. Smith, Representing Investors of Caraco Pharmaceutical Laboratories, Ltd., Announces Class Action Lawsuit

Lifeline Biotechnologies, Inc. - Lifeline Biotechnologies Files First Warning System™ With the FDA

Marketing and Licensing Agreements - Hagens Berman Sobol Shapiro: Vytorin and Zetia Makers Settle Class-Action Suit With Proposed $41.5 Million

Medifacts International, Inc. - Medifacts International and Suzuken Announce Successful Completion of a Japanese Study Utilizing WebHeart®

Mesynthes Ltd. - Mesynthes Seeks U.S. FDA Clearance for First Product Employing Proprietary Endoform™ Extracellular Matrix Technology

Midwest Medical Aesthetics - Midwest Medical Aesthetics Helps Defy Nature and Wrinkles with Artefill

Myeloma - Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX-0401 (Perifosine) in the Treatment of Multiple Myeloma

Myeloma - terna Zentaris Partner, Keryx, Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine (KRX-0401) for the Treatment of Multiple Myeloma

NeuroLogica Corp. - NeuroLogica Corporation Receives Approval Registration To Market its CereTom Portable CT Scanner throughout Brazil

NewCardio, Inc. - NewCardio Announces Master Services Agreement With Dedicated Phase I

Nucryst Pharmaceuticals Corp. - NUCRYST announces 2009 second quarter financial results

Orthovita, Inc. - Orthovita Reports 2009 Second Quarter Financial Results

OSI Pharmaceuticals, Inc. - New Data from Phase III SATURN Study Showed Tarceva Extended Survival in Patients with Advanced Non-Small Cell Lung Cancer When Used Immediately after Initial Chemotherapy

Osteoporosis - Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis

Pain Management - Nanotechnology Transforms Pain Relief

Pandemics - Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA

Perrigo Company - Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ

Pharmaceuticals - Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results

Pharmaceuticals - NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development

Pharmaceuticals - Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

Pharmaceuticals - QRxPharma Initiates Comparative Phase 2 Proof-of-Concept Study for MoxDuo IV Pain Therapy

Pharmaceuticals - URL Pharma Acquires PharmPro Manufacturing Facility and Equipment

Pharmaceuticals - ViroPharma Announces Support by Advisory Committee of the Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride

Pharmaceuticals - Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG

Pneumococcal Disease - Israel Adds Wyeth's 7-valent Pneumococcal Conjugate Vaccine (PCV7) to their National Immunisation Programme

Pneumonia - Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia

Precision Dynamics-TimeMed - America's Leading Hospitals Use Precision Dynamics-TimeMed Products to Improve Patient ID and Safety

ProChon Biotech, Ltd. - ProChon Biotech Selects Averion International for the BioCart™ Cartilage Regeneration System Study

Progenics Pharmaceuticals, Inc. - New Delivery System for RELISTOR in Pre-Filled Syringes Submitted for U.S. and European Marketing Approval

Prostate Cancer - Ferring Pharmaceuticals Announces Trade Name FIRMAGON(R) (degarelix for injection) for Advanced Prostate Cancer Treatment

RCA Research - RCA Research Announces Acquisition

Regulatory Actions - Exciton Technologies receives FDA approval to market exSALT(TM)

Regulatory Actions - FDA Approves Sculptra®Aesthetic, a Facial Injectable for Correction of Nasolabial Folds and other Facial Wrinkles

Regulatory Actions - FDA extends review of Pennsaid(R) diclofenac sodium topical solution

Regulatory Actions - Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)

Repros Therapeutics Inc. - Repros Therapeutics Inc. Suspends Dosing of Proellex® and Provides Update on Financial Status

Research and Markets - The Grey House Homeland Security Directory - Access Thousands of Contacts and Resources for Homeland Security

Research and Markets Ltd. - An In-Depth Report on Canada's Medical Device Market

Respiratory Therapy - Covidien Receives FDA Clearance for its Puritan Bennett 840 Ventilator System with New Automatic Leak Adjustments Software Option

Sadove Cosmetic Surgery - North Florida Sculptra Expert, Richard Sadove MD, Comments on FDA Approval

Schizophrenia - FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

Schizophrenia - INVEGA(R) Approved as the First and Only Treatment for Schizoaffective Disorder

SmallCapVoice.com - A New Audio Interview with Carrie Snyder, Independent Analyst Covering BioElectronics Corp., is now at SmallCapVoice.com

SS Choice, Llc - Electronic Cigarette Company eCigarettesChoice.com Claims FDA Study Proves E-Cigarettes Are Safer Than Tobacco Cigarettes

Surgery - Atlantic Plastic Surgery Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler

The Chao Center - Lilly, Chao Center, PDA Partner With Russian Officials to Improve Quality of Global Drug Manufacturing, Distribution

Therapy - Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval

Thromboembolism - Data Show ATryn® Effectively Prevents Serious Blood Clots in Patients with Hereditary Antithrombin Deficiency

Thrombosis - Effient(TM) is Now Available in Pharmacies

Thrombosis - New Catheter Mimics Nature

Tissue Engineering - Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product

Titan Spine, LLC - Titan Spine's Interbody Device Participates in the Fusion Process

US Pharmacopeia - Patient safety advanced by revised heparin standards

Validation and Compliance Institute, Llc - Validation & Compliance Institute, LLC, to Provide Medical Device Regulatory Training for the University of Michigan's Medical Innovation Center

Vertigo - Florida clinic adds new leading technology to help dizzy patients

Women's Health - Omega-3 Fatty Acids Key to Fetal Development Possible Mercury Contamination Concerns in Some Fish Oil Avoided with Plant-based DHA in PreNexa® Prenatal Vitamins

XDx, Inc. - XDx Completes $14.4 Million Series G Financing